Measuring Aided Language Development
Part of paid clinical trials in Orlando, Florida.
- Sponsor
- University of Central Florida
- Study ID
- NCT06512168
- Status
- Recruiting
Conditions
- Apraxia of Speech
- Cerebral Palsy
- Down Syndrome
- Speech Disorders in Children
- Speech Sound Disorder
- Speech and Language Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 42 Months - 60 Months
- Healthy Volunteers
- Not accepted
Interventions
- AAC Generative Language Intervention — BEHAVIORALAided AAC Language Input/Output Intervention
Study Details
The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).
Key Dates
- Start date
- Apr 1, 2025
- Status verified
- May 2025
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Treatment GroupAAC Generative Language Intervention
Primary Outcome Measure
Aided AAC Utterance Length [ Time Frame: 24 Months ]
Central Contacts
- Jennifer Kent-Walsh, PhD407-823-4800
- Cathy Binger, PhD505-277-4453
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Central Florida - Innovative Center | Orlando | Florida | 32826 |
Find similar trials in Orlando, FL
By research site
Related Studies
- Clinical Orthopaedic Data Bank (Acute and Chronic)Recruiting · University of Florida · Gainesville, Florida
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)PHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute LeukemiaRecruiting · Children's Oncology Group · Birmingham, Alabama